Kai Liu1, Shousheng Liu2, Luan Li1, Shikai Wang3, Xinxin Fan4, Xingjiang Wu4, Guangjun Shi5, Hongtao Zong6. 1. Department of Hepatobiliary Surgery, Qingdao Municipal Hospital, Qingdao, Shandong Province, P. R. China. 2. Department of Central Laboratory, Qingdao Municipal Hospital, Qingdao, Shandong Province, P. R. China. 3. Department of General Surgery, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, P. R. China. Electronic address: chinashdliukai@163.com. 4. Department of General Surgery, East Region Military Command General Hospitall, Medical School of Nanjing University, Nanjing, Jiangsu Province, P. R. China. 5. Department of Hepatobiliary Surgery, Qingdao Municipal Hospital, Qingdao, Shandong Province, P. R. China. Electronic address: 769320450@qq.com. 6. Department of General Surgery, Wuxi No. 9 People's Hospital affiliated to Soochow University, Wuxi, Jiangsu Province, P. R. China. Electronic address: 595400072@qq.com.
Abstract
BACKGROUND: This retrospective study aims to investigate the effects of the endovascular and surgical strategy for treating patients with acute mesenteric venous thrombosis (AMVT). METHODS: We retrospectively studied 68 patients with AMVT who underwent treatment in Jinling Hospital during the period from January 2009 to December 2014. The mean age was 45 ± 12 years (range 20-72 years). All patients were treated by using the combined treatment that included endovascular treatment, damage control surgery, surgical intensive care, and intestinal rehabilitation treatment. Clinical outcomes and complications were compared during the follow-up period. RESULTS: All the 68 cases received anticoagulant treatment. However, only 24 received the endovascular intervention, 19 received surgical resection, and 25 patients received endovascular treatment combined with bowel resection. The overall mortality rate was 2.94% (2 cases). Bowel resection range significantly decreased (92 ± 14 cm vs. 162 ± 27 cm, t = -2.377, P = 0.022) in the combination therapy group, when compared with the surgery group. During the 1-year follow-up period, 4 cases suffered from short bowel syndrome. CONCLUSIONS: Our study indicates that AMVT can be successfully treated with the early improvement of intestinal blood circulation. Further, our applied combined approach showed a favorable outcome in mesenteric thrombosis patients and reduced the mortality rate by improving the prognosis significantly.
BACKGROUND: This retrospective study aims to investigate the effects of the endovascular and surgical strategy for treating patients with acute mesenteric venous thrombosis (AMVT). METHODS: We retrospectively studied 68 patients with AMVT who underwent treatment in Jinling Hospital during the period from January 2009 to December 2014. The mean age was 45 ± 12 years (range 20-72 years). All patients were treated by using the combined treatment that included endovascular treatment, damage control surgery, surgical intensive care, and intestinal rehabilitation treatment. Clinical outcomes and complications were compared during the follow-up period. RESULTS: All the 68 cases received anticoagulant treatment. However, only 24 received the endovascular intervention, 19 received surgical resection, and 25 patients received endovascular treatment combined with bowel resection. The overall mortality rate was 2.94% (2 cases). Bowel resection range significantly decreased (92 ± 14 cm vs. 162 ± 27 cm, t = -2.377, P = 0.022) in the combination therapy group, when compared with the surgery group. During the 1-year follow-up period, 4 cases suffered from short bowel syndrome. CONCLUSIONS: Our study indicates that AMVT can be successfully treated with the early improvement of intestinal blood circulation. Further, our applied combined approach showed a favorable outcome in mesenteric thrombosispatients and reduced the mortality rate by improving the prognosis significantly.
Authors: Khaled Alnahhal; Beau B Toskich; Samuel Nussbaum; Zhuo Li; Young Erben; Albert G Hakaim; Houssam Farres Journal: World J Clin Cases Date: 2022-01-07 Impact factor: 1.337